skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Evaluating the potential of gold, silver, and silica nanoparticles to saturate mononuclear phagocytic system tissues under repeat dosing conditions

Journal Article · · Particle and Fibre Toxicology
 [1];  [1];  [2];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [3];  [3];  [2];  [2];  [2];  [2]; ORCiD logo [1]
  1. U.S. Food and Drug Administration (FDA), Silver Spring, MD (United States). Center for Drug Evaluation and Research
  2. U.S. Food and Drug Administration (FDA), Jefferson, AR (United States). National Center for Toxicological Research
  3. U.S. Food and Drug Administration (FDA), Silver Spring, MD (United States). Center for Devices and Radiological Health

Background: As nanoparticles (NPs) become more prevalent in the pharmaceutical industry, questions have arisen from both industry and regulatory stakeholders about the long term effects of these materials. This study was designed to evaluate whether gold (10 nm), silver (50 nm), or silica (10 nm) nanoparticles administered intravenously to mice for up to 8 weeks at doses known to be sub-toxic (non-toxic at single acute or repeat dosing levels) and clinically relevant could produce significant bioaccumulation in liver and spleen macrophages. Results: Repeated dosing with gold, silver, and silica nanoparticles did not saturate bioaccumulation in liver or spleen macrophages. While no toxicity was observed with gold and silver nanoparticles throughout the 8 week experiment, some effects including histopathological and serum chemistry changes were observed with silica nanoparticles starting at week 3. No major changes in the splenocyte population were observed during the study for any of the nanoparticles tested. Conclusions: The clinical impact of these changes is unclear but suggests that the mononuclear phagocytic system is able to handle repeated doses of nanoparticles.

Research Organization:
U.S. Food and Drug Administration (FDA), Silver Spring, MD (United States). Center for Drug Evaluation and Research; Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE Office of Science (SC)
Grant/Contract Number:
SC0014664
OSTI ID:
1626913
Journal Information:
Particle and Fibre Toxicology, Vol. 14, Issue 1; ISSN 1743-8977
Publisher:
BioMed CentralCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 23 works
Citation information provided by
Web of Science

References (27)

Product quality for nanomaterials: current U.S. experience and perspective: Product quality for nanomaterials
  • Tyner, Katherine M.; Zou, Peng; Yang, Xiaochuan
  • Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Vol. 7, Issue 5 https://doi.org/10.1002/wnan.1338
journal January 2015
Distribution of silver nanoparticles in pregnant mice and developing embryos journal October 2011
Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats journal March 2010
Minireview: Nanoparticles and the Immune System journal February 2010
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration journal April 2008
A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity journal February 2010
Horizon scan of nanomedicinal products journal May 2015
Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size journal October 2008
Silica in Plants: Biological, Biochemical and Chemical Studies journal September 2007
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery journal January 2004
Tissue and cellular distribution of gold nanoparticles varies based on aggregation/agglomeration status journal February 2012
Cells Involved in the Capture of Nanoparticles in Hematopoietic Organs journal September 1996
Assessment of the In Vivo Toxicity of Gold Nanoparticles journal May 2009
Nanosafety Research-Are We on the Right Track? journal January 2014
Processing Pathway Dependence of Amorphous Silica Nanoparticle Toxicity: Colloidal vs Pyrolytic journal September 2012
Shape Dependence of Gold Nanoparticles on In Vivo Acute Toxicological Effects and Biodistribution journal February 2011
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: What should be the policy? journal January 2011
The induction of epigenetic regulation of PROS1 gene in lung fibroblasts by gold nanoparticles and implications for potential lung injury journal October 2011
Protracted elimination of gold nanoparticles from mouse liver journal June 2009
Biodistribution and toxicity of intravenously administered silica nanoparticles in mice journal November 2009
The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction journal March 2016
Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles In Vitro via Plate-Based, Flow Cytometry, and Coulter Counter Assays journal January 2012
Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles journal April 2009
Assessment of total silver and silver nanoparticle extraction from medical devices journal November 2015
Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats journal November 2013
Analytical characterization of gold nanoparticle primary particles, aggregates, agglomerates, and agglomerated aggregates journal February 2011
Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies journal January 2011

Cited By (8)

Si nanocrystal solution with stability for one year journal January 2018
Immunostimulant and biocompatible gold and silver nanoparticles synthesized using the Ulva intestinalis L. aqueous extract journal January 2019
The effects of gold nanoparticles on the human blood functions journal May 2018
The Effect of Stabilisation Agents on the Immunomodulatory Properties of Gold Nanoparticles Obtained by Ultrasonic Spray Pyrolysis journal December 2019
N-Acetylcysteine reverses silver nanoparticle intoxication in rats text January 2019
The effects of gold nanoparticles on the human blood functions text January 2018
N-Acetylcysteine reverses silver nanoparticle intoxication in rats text January 2019
The effects of gold nanoparticles on the human blood functions text January 2018